TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML patients with diverse mutationsSafety continues to be a notable hallmark of ...

ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...

Artificial intelligence is rapidly transforming clinical medicine, with AI-powered tools increasingly being used for ...

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell ...

Marijuana breeders may be able to design new strains and speed up their growing cycles by utilizing artificial intelligence ...

US AI-focused start-up Formation Bio has entered a deal with Lynk Pharmaceuticals for worldwide rights, excluding Greater ...

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Biotoday announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to ...

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

The dual objective is to prevent migration and impose US domination in the ‘Western Hemisphere’. But Latin American leaders will still wish to work with China.

Formation Bio and Lynk Pharmaceuticals today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to LNK01006, a next generation central nervous system (CNS)–penetrant ...